Atezolizumab as first-line treatment in cisplatin-ineligible patients with locally advanced and metastatic urothelial carcinoma: a single-arm, multicentre, phase 2 trial Academic Article Article uri icon

Overview

MeSH Major

  • Antibodies, Anticardiolipin
  • Antiphospholipid Syndrome
  • beta 2-Glycoprotein I

abstract

  • F Hoffmann-La Roche, Genentech.

authors

publication date

  • January 7, 2017

Research

keywords

  • Academic Article

Identity

Digital Object Identifier (DOI)

  • 10.1016/S0140-6736(16)32455-2

PubMed ID

  • 27939400

Additional Document Info

start page

  • 67

end page

  • 76

volume

  • 389

number

  • 10064